ICU
SeaStar Medical Holding Corporation Common Stock
Nasdaq · usd
SeaStar Medical Holding Corporation Common Stock (ICU) trades at $0.9350 (-11.00%) as of 7:44:26 PM EST on Nov 20, 2026, -67.19% over the past month. Market cap is $4.97M, with 1.3 days to cover in short interest.
Stock performance
How SeaStar Medical Holding Corporation Common Stock (ICU) stock has performed from one day to one year, with its 52-week range.
- 1D
- -10.95%
- 1W
- +11.52%
- 1M
- -67.19%
- YTD
- -61.04%
- 1Y
- -69.36%
- 52-wk range
- $0.76 – $5.38
Key statistics
Today's trading snapshot for ICU: day range, open, previous close, volume and market cap.
- Day range
- $0.89 – $1.04
- Open
- $0.98
- Prev close
- $1.05
- Volume
- 135.82K
- Market cap
- $4.97M
- Shares out
- 5.32M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for SeaStar Medical Holding Corporation Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 2.31
- P/B
- 10.65
- P/FCF
- —
- ROE
- -3130.9%
- ROA
- -276.5%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 20, 2026
8-K filings
Material corporate events SeaStar Medical Holding Corporation Common Stock has disclosed to the SEC on Form 8-K.
- Listing deficiency noticeNov 20, 2026
On November 20, 2026, SeaStar Medical Holding Corporation (the "Company") received a letter ... notifying the Company that ... it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires ... a minimum of $2.5 million in stockholder's equity for continued listing.
- Quarterly earningsNov 12, 2026
On November 11, 2026, SeaStar Medical Holding Corp. issued a press release announcing its financial condition and results of operations for the three and nine months ended September 30, 2026.
- Regulatory decisionNov 3, 2026
On November 3, 2026, the Company issued a press release announcing that the United States Food and Drug Administration has determined that the QUELIMMUNE Pediatric SAVE Surveillance Registry ("SAVE Registry") has fulfilled post-approval study requirements as outlined in the original Humanitarian Device Exemption approval of QUELIMMUNE.
- Private placementOct 5, 2026
The New Warrants, PA Warrants, New Warrant Shares and PA Warrant Shares were sold and issued without registration under the Securities Act of 1933, as amended (the "Securities Act"), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering and Rule 506 promulgated under the Securities Act as sales to accredited investors.
- Executive compensation changeJul 1, 2026
On June 25, 2026, the Compensation Committee of the Board of Directors of the SeaStar Medical Holding Corporation (the "Company") approved retention bonuses for each of Eric Schlorff and Kevin Chung ("Executives") in the amount set forth below, (a) one-third of which will vest and be payable on July 1, 2026, (b) one-third of which will vest and be payable on November 1, 2026, and (c) one-third of which will vest and be payable on March 1, 2027, in each case subject to continued employment through the applicable vesting date. Executives will receive an additional amount equal to 25% of each payment in shares of the Company's common stock under the Company's 2022 Omnibus Incentive Plan.
Dividend history and stock splits
SeaStar Medical Holding Corporation Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-10Jan 5, 2026
- 1-for-25Jun 10, 2024
ICU short interest
How heavily ICU is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.3
- Short interest
- 175.17K
- Avg volume
- 132.1K
As of · reported to FINRA twice monthly.
ICU news
The latest news and headlines about SeaStar Medical Holding Corporation Common Stock (ICU).
- Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving PremarketpositiveBenzinga· Sep 25, 2025
- SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025positiveGlobeNewswire Inc.· Aug 7, 2025
- SeaStar Medical to Report First Quarter Financial Results on May 14, 2025positiveGlobeNewswire Inc.· May 7, 2025
- SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025positiveGlobeNewswire Inc.· Mar 24, 2025
- SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal TrialpositiveGlobeNewswire Inc.· Dec 23, 2024
Frequently asked questions
What is the SeaStar Medical Holding Corporation Common Stock (ICU) stock price today?
SeaStar Medical Holding Corporation Common Stock (ICU) is trading at $0.9350 (-11.00% on the day) as of 7:44:26 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is SeaStar Medical Holding Corporation Common Stock?
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic…
What is the short interest in ICU?
As of Oct 30, 2026, ICU has 175.17K shares short and 1.3 days to cover.
What exchange is ICU listed on?
SeaStar Medical Holding Corporation Common Stock (ICU) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of ICU with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ICU analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.